[Certain principles for differential utilization of metabolic treatment preparations in the complex therapy of mental disorders].

Abstract

A study of 246 patients (with schizophrenia, manic depressive psychoses and psychoorganic syndrome) treated by some drugs of a metabolic action (encephalotropic", "nootropic" drugs, piracetam, piriditol and pantogam) permitted one to determine the place of these preparations in a comprehensive treatment of mental disorders. On the basis of clinical studies of the above-mentioned preparations, the conclusion is made about desirability (and in some cases about necessity) of including them into pharmacotherapy. During such studies certain traits of the clinical effect in each of these drugs was examined, permitting the comparative spectra of the pharmacological activity of piracetam, piriditol and pantogam to be determined. The clinical studies of these patients indicate the necessity of a differentiated use of the mentioned drugs having in view the state of the patient and detected clinical profile of the drugs.

• Authors: G Ia Avrutskiĭ, N B Laskova
• Journal: Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952) (Zh Nevropatol Psikhiatr Im S S Korsakova) Vol. 79 Issue 8 Pg. 1077-83 ( 1979) ISSN: 0044-4588 [Print] Russia (Federation)
• Vernacular Title: Nekotorye printsipy differentsirovannogo primeneniia preparatov metabolicheskoĭ terapii v kompleksnom lechenii psikhicheskikh zabolevaniĭ.
• PMID: 484144 (Publication Type: Comparative Study, Journal Article)

Chemical References

• Pyridines
• Pyrrolidinones
• pantogab
• Pantothenic Acid
• gamma-Aminobutyric Acid
• Pyrithioxin
• Piracetam

Topics

• Adolescent
• Adult
• Aged
• Bipolar Disorder (drug therapy)
• Brain Injuries (complications)
• Humans
• Infections (complications)
• Mental Disorders (drug therapy)
• Middle Aged
• Neurocognitive Disorders (drug therapy, etiology)
• Pantothenic Acid (analogs & derivatives, therapeutic use)
• Piracetam (therapeutic use)
• Pyridines (therapeutic use)
• Pyrithioxin (therapeutic use)
• Pyrrolidinones (therapeutic use)
• Schizophrenia (drug therapy)
• Skull (injuries)
• gamma-Aminobutyric Acid (analogs & derivatives)